发布求助
文献互助 智能选刊 最新文献

Dialogues in cardiovascular medicine : DCM最新文献

筛选
英文 中文
Gene therapy for myocardial infarction-associated congestive heart failure: how far have we got? 基因治疗心肌梗死相关充血性心力衰竭:我们取得了多大进展?
Dialogues in cardiovascular medicine : DCM Pub Date : 2009-01-01
H Kirk Hammond, Tong Tang
{"title":"Gene therapy for myocardial infarction-associated congestive heart failure: how far have we got?","authors":"H Kirk Hammond,&nbsp;Tong Tang","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>With the advancement of vectors, delivery methods, and newly identified molecular targets, preclinical studies have shown that gene transfer is effective in improving left ventricular contractility and attenuating deleterious left ventricular remodeling in myocardial infarction-associated congestive heart failure (CHF). We are optimistic that these favorable effects will also be seen when tested in patients with CHF associated with myocardial infarction, as well as in patients with CHF from other etiologies. Gene therapy has the potential to be tailored to meet the needs of individual patients. Moreover, when used in conjunction with pharmacological and device management of the patient with CHF, it provides hope for a brighter future for the 23 million patients worldwide with this devastating disease.</p>","PeriodicalId":88470,"journal":{"name":"Dialogues in cardiovascular medicine : DCM","volume":"14 1","pages":"27-51"},"PeriodicalIF":0.0,"publicationDate":"2009-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3119547/pdf/nihms-286869.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29961145","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
GENE AND CELL THERAPY FOR LIFE-THREATENING CARDIAC ARRHYTHMIAS. 危及生命的心律失常的基因和细胞治疗。
Dialogues in cardiovascular medicine : DCM Pub Date : 2009-01-01
Michael R Rosen, Peter Danilo, Richard B Robinson
{"title":"GENE AND CELL THERAPY FOR LIFE-THREATENING CARDIAC ARRHYTHMIAS.","authors":"Michael R Rosen,&nbsp;Peter Danilo,&nbsp;Richard B Robinson","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Gene and cell therapies of cardiac arrhythmias are nascent fields whose raison d'etre derives from (1) the problematic state of arrhythmia treatment today (especially atrial and ventricular tachyarrhythmias for which drugs, devices and ablation remain more stopgaps then optimal interventions), and (2) the opportunity to learn and potentially treat and cure by exploring new technologies. The state of antiarrhythmic therapy and new directions being taken are reviewed.</p>","PeriodicalId":88470,"journal":{"name":"Dialogues in cardiovascular medicine : DCM","volume":"14 1","pages":"44-51"},"PeriodicalIF":0.0,"publicationDate":"2009-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2828741/pdf/nihms119505.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"28744516","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PRIMARY AND SECONDARY PREVENTION OF STROKE 中风的一级和二级预防
Dialogues in cardiovascular medicine : DCM Pub Date : 1900-01-01 DOI: 10.4324/9780203211410_chapter_2
P. Gorelick
{"title":"PRIMARY AND SECONDARY PREVENTION OF STROKE","authors":"P. Gorelick","doi":"10.4324/9780203211410_chapter_2","DOIUrl":"https://doi.org/10.4324/9780203211410_chapter_2","url":null,"abstract":"We have made an attempt to systematize risk factors of primary and repeated ischemic strokes development. The divisions of the corrected and not corrected have been introduced in basis of systematization. The main tasks of primary and secondary prophylaxis of ischemic strokes have been distinguished. The realization of secondary prophylaxis is quite possible in modern stage and in the conditions of existing social and economic difficulties. So in comparison with the primary prophylaxis that sphere is less expensive. The affected possibility to the corrected risk factors has been determined, namely adequate therapy administered in time, complicated by the ischemic stroke development. The basic categories have been determined to carry out primary and secondary prophylaxis of ischemic strokes. They are teachers, psychologists, prophylaxis and curative institutions workers.","PeriodicalId":88470,"journal":{"name":"Dialogues in cardiovascular medicine : DCM","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70580794","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
首页 上一页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信